Variants in adenosine A1 receptor (ADORA1) were associated with endothelial dysfunction in the entire cohort, whereas variants in adenosine A3 receptor (ADORA3) and lipoprotein(a) (LPA) had the strongest associations with increased risk of endothelial dysfunction in women only. This evidence concerns the gene ADORA3 and endothelial dysfunction.